Clinical Trials Browser

Phase 2 × Osteosarcoma × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

NCT02502786 2025-10-07

Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma

Phase 2 Active not recruiting

Osteosarcoma

NCT00066365 2015-03-30

Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma

Phase 2 Completed

49 enrolled 21 charts

Neoplasm Metastasis, Sarcoma, Osteosarcoma